{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:55:19Z","timestamp":1792670119362,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR000421"],"award-info":[{"award-number":["KL2TR000421"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K07CA172298"],"award-info":[{"award-number":["K07CA172298"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA118699"],"award-info":[{"award-number":["R01CA118699"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA107333"],"award-info":[{"award-number":["R01CA107333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K05CA142885"],"award-info":[{"award-number":["K05CA142885"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA076366"],"award-info":[{"award-number":["R01CA076366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA74794"],"award-info":[{"award-number":["U01CA74794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1053\/j.gastro.2014.09.038","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T20:47:46Z","timestamp":1412110066000},"page":"77-87.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":344,"title":["Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival"],"prefix":"10.1053","volume":"148","author":[{"given":"Amanda I.","family":"Phipps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea N.","family":"Burnett-Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Weisenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Sinicrope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Rosty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly A.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2014.09.038_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2006.02549.x","article-title":"Classification of colorectal cancer based on correlation of clinical, morphological and molecular features","volume":"50","author":"Jass","year":"2007","journal-title":"Histopathology"},{"key":"10.1053\/j.gastro.2014.09.038_bib2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1053\/j.gastro.2009.12.066","article-title":"Role of the serrated pathway in colorectal cancer pathogenesis","volume":"138","author":"Leggett","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.09.038_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.gastro.2013.05.001","article-title":"Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women","volume":"145","author":"Samadder","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.09.038_bib4","first-page":"1193","article-title":"Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study","volume":"9","author":"Samowitz","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2014.09.038_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1054\/bjoc.2001.1964","article-title":"Kirsten ras mutations in patients with colorectal cancer: the \u2018RASCAL II\u2019 study","volume":"85","author":"Andreyev","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2014.09.038_bib6","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-09-1570","article-title":"KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803","volume":"15","author":"Ogino","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib7","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1158\/1078-0432.CCR-11-3210","article-title":"Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF-wild-type colorectal cancers","volume":"18","author":"Imamura","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/bjc.2013.118","article-title":"KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers","volume":"108","author":"Phipps","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2014.09.038_bib9","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1055-9965.EPI-12-0674","article-title":"BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics","volume":"21","author":"Phipps","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2014.09.038_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of\u00a0KRAS, BRAF, NRAS, and PIK3CA mutations on the\u00a0efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","article-title":"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial","volume":"28","author":"Roth","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib12","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/annonc\/mdq258","article-title":"The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients","volume":"21","author":"Farina-Sarasqueta","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/DCR.0b013e31823c08b3","article-title":"BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis","volume":"55","author":"Kalady","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2014.09.038_bib14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1078-0432.CCR-11-2246","article-title":"Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803","volume":"18","author":"Ogino","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib15","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.ejca.2010.05.009","article-title":"Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data","volume":"46","author":"Guastadisegni","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2014.09.038_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000069311","article-title":"Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer","volume":"64","author":"Wang","year":"2003","journal-title":"Oncology"},{"key":"10.1053\/j.gastro.2014.09.038_bib17","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-07-1489","article-title":"Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer","volume":"14","author":"French","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib18","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-05-0404","article-title":"Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers","volume":"65","author":"Samowitz","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.2008.155473","article-title":"CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer","volume":"58","author":"Ogino","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2014.09.038_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1440-1827.2007.02197.x","article-title":"Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS\/BRAF mutation","volume":"58","author":"Lee","year":"2008","journal-title":"Pathol Int"},{"key":"10.1053\/j.gastro.2014.09.038_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","article-title":"Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer","volume":"29","author":"Hutchins","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1245\/s10434-009-0713-0","article-title":"KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer","volume":"17","author":"Nash","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fonc.2012.00007","article-title":"Stratification and prognostic relevance of Jass's molecular classification of colorectal cancer","volume":"2","author":"Zlobec","year":"2012","journal-title":"Front Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib24","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1158\/1055-9965.EPI-07-0648","article-title":"Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer","volume":"16","author":"Newcomb","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2014.09.038_bib25","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1158\/0008-5472.CAN-06-4275","article-title":"Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women","volume":"67","author":"Newcomb","year":"2007","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib26","first-page":"5248","article-title":"A\u00a0National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2002.20.4.1043","article-title":"Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors","volume":"20","author":"Lindor","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","article-title":"Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry","volume":"10","author":"Shia","year":"2008","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1053\/j.gastro.2014.09.038_bib29","doi-asserted-by":"crossref","first-page":"e11636","DOI":"10.1371\/journal.pone.0011636","article-title":"Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics","volume":"5","author":"Buchanan","year":"2010","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2014.09.038_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2014.09.038_bib31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ejca.2006.02.023","article-title":"Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years","volume":"42","author":"Alsop","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2014.09.038_bib32","unstructured":"The Cancer Genome Atlas. cBioPortal for Cancer Genomics. http:\/\/www.cbioportal.org\/public-portal\/index.do. Computational Biology Center, Memorial Sloan-Kettering Cancer Center,\u00a02013."},{"key":"10.1053\/j.gastro.2014.09.038_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1476-4598-13-135","article-title":"Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review","volume":"13","author":"Imamura","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1053\/j.gastro.2014.09.038_bib34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ng1834","article-title":"CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer","volume":"38","author":"Weisenberger","year":"2006","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2014.09.038_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/gut.2005.082933","article-title":"CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies","volume":"55","author":"Ogino","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2014.09.038_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1101\/gr.117523.110","article-title":"Genome-scale analysis of aberrant DNA methylation in colorectal cancer","volume":"22","author":"Hinoue","year":"2012","journal-title":"Genome Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jclinepi.2006.01.015","article-title":"Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example","volume":"59","author":"van der Heijden","year":"2006","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2014.09.038_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mpr.329","article-title":"Multiple imputation by chained equations: what is it and how does it work?","volume":"20","author":"Azur","year":"2011","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib39","series-title":"International Classification of Diseases","year":"2007"},{"key":"10.1053\/j.gastro.2014.09.038_bib40","series-title":"Modeling survival data: extending the Cox model","author":"Therneau","year":"2000"},{"key":"10.1053\/j.gastro.2014.09.038_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0962280206079046","article-title":"A\u00a0review of modern multiple hypothesis testing, with particular attention to the false discovery proportion","volume":"17","author":"Farcomeni","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1053\/j.gastro.2014.09.038_bib42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","article-title":"Systematic review of microsatellite instability and colorectal cancer prognosis","volume":"23","author":"Popat","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/jnci\/djt173","article-title":"Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication","volume":"105","author":"Lochhead","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2014.09.038_bib44","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1200\/JCO.2003.03.123","article-title":"Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability","volume":"21","author":"Ward","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib45","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/bjs.6683","article-title":"Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer","volume":"96","author":"Sanchez","year":"2009","journal-title":"Br J Surg"},{"key":"10.1053\/j.gastro.2014.09.038_bib46","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.2008.18.2071","article-title":"Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803","volume":"27","author":"Bertagnolli","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib47","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.09.038_bib48","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1053\/j.gastro.2010.12.035","article-title":"5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer","volume":"140","author":"Jover","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.09.038_bib49","first-page":"63","article-title":"Effect of KRAS mutational status in advanced colorectal cancer on the outcomes of anti-epidermal growth factor receptor monoclonal antibody therapy: a systematic review and meta-analysis","volume":"10","author":"Lin","year":"2011","journal-title":"Clin Colorectal Cancer"},{"key":"10.1053\/j.gastro.2014.09.038_bib50","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.ejca.2012.02.057","article-title":"Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials","volume":"48","author":"Bokemeyer","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2014.09.038_bib51","unstructured":"Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database. Incidence - SEER 13 Regs Research Data, Nov 2011 Sub, Vintage 2009 Pops (1992\u20132009) <Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total US, 1969-2010 Counties. In: National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch, released April 2012, based on the November 2011 submission. Available at www.seer.cancer.gov. Accessed March 10, 2014."}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508514011925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508514011925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:08:41Z","timestamp":1758035321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508514011925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0016508514011925"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2014.09.038","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.719131045.793502499","asserted-by":"object"}]},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2014.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}